The first year of the new "Spike Man"
Release time:
2021-03-01
2021 Spring Festival is of great significance to me. In the cold window of 20 , I will finally enter the society in 2020 , join Jianfeng Group and set foot on my job.
The first Spring Festival of official work is very different from previous years. During the days of studying, the winter vacation lasting more than a month is leisurely. There are only seven days left in the Spring Festival holiday after work, and the days at home become precious. When I was in college, my suitcase was full of dirty clothes for my mother to wash. This year, my suitcase was a specialty of Jinhua and Huangshi. I was looking forward to sharing the joy of working and earning money with my family. During the Spring Festival holiday on campus, games, variety shows and one reunion after another are indispensable. This year, I seem to have some work pressure and want to spend more time on reading and thinking.
These changes are not deliberate, but more imperceptibly become habits. When I first stepped into the Peak Building a year ago, how could I know that I had really grown up a year later. Looking back on the first year of work, according to the company's arrangement, I went to Jianfeng Pharmaceutical Factory, Jianfeng Health and Daye Jianfeng for internships, and was familiar with the organizational structure and management mode of the group and its subsidiaries. During this time, I met "Spike Man " in different positions.
In the Engineering Security Department of Jinxi Pharmaceutical Factory, colleague Zhu Guoping continuously debugged the frequency conversion fan of the cool warehouse at a high temperature close to 40 degrees. In order to solve technical problems, he often used the off-duty time to consult data and study hard without complaint. My sisters, aunts and uncles in the peak health care product workshop are often busy sweating in the cold autumn. In order to save production time, it is a luxury to drink a mouthful of water. Master Hu Changwei of the inspection team of Daye Peak Manufacturing Department patiently explained to me the knowledge of cement kilns and the cement production technology of the whole plant. As far as I know, Master Hu, who is old enough to be my father, has silently devoted 12 years to this ordinary post, even on New Year's Eve, and has been fighting in the front line of production. These lovely peak predecessors not only taught me knowledge and skills, but also made me realize the valuable qualities of peak people.
What I feel most deeply is that the peak people have the courage to cut through difficulties and innovate. Whether it is 1958 when our old predecessors set up Jinhua Cement Factory in the Temple of the Wise, or when the new era peak people went to Daye in Hubei, Pu'er in Yunnan and Huangping in Guizhou to set up cement production enterprises, the peak people did not fear hardship in material conditions, seized new opportunities in hills and slopes, dared to try and overcome difficulties.
Then there is dedication and dedication. Colleagues in the pharmaceutical factory have to drive 30 kilometers to and from work every day, and the one-way journey takes 90 minutes. The daily work starts from the factory car. In order to catch up with the construction period, it is common for the healthy production and packaging workshop to work overtime, and it is their motto to keep orders with sweat. The inspection team of cement enterprises, regardless of severe cold and heat, regular inspection throughout the year 365 days, the inspection colleagues who are over 50 years old work shifts day and night, working for 12 hours, and do not eat and turn around in case of emergency repair tasks.
Such touching stories are by no means unique in the subsidiaries of Jianfeng. Influenced by their spirit and quality, I have undergone a transformation when I am about to grow up to be one year old, and I welcome the new year with high morale. At the beginning of this new year, I would like to say thank you to all the teachers, leaders and colleagues who have taught me and will teach me! I wish Jianfeng Group and all Jianfeng people a new atmosphere in the New Year, by going up one storey!
(Wei Deng Changhong)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31